Close Menu

Illumina SARS-CoV-2 Data Toolkit

Illumina has released a suite of data analysis tools and workflow functionality for researchers sequencing SARS-CoV-2, the virus that causes COVID-19.

The toolkit helps detect and identify the viral genome sequence in samples and contribute findings to public databases directly from BaseSpace Sequence Hub. It includes new and updated DRAGEN functionality, including a new RNA pathogen detection pipeline, a metagenomics pipeline for outbreak surveillance, an SRA import app, and a GISAID sharing app. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.